Iterion Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative treatments for rare and orphan diseases. With a dedication to improving the lives of patients with unmet medical needs, Iterion Therapeutics is committed to advancing novel therapeutics through the drug development process. Our team of experts are passionate about making a difference in the lives of those affected by rare diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

9 Patents

#514 in Houston, TX

#2,058 in Texas

#32,565 in US

Houston, TX, United States of America

Iterion Therapeutics, Inc.

Forward Citations = 1

10 inventors:

Drazen Ostovic (8 out of 15 patents)

Gowri Sukumar (8 out of 8 patents)

Stephen Horrigan (1 out of 3 patents)

4. Steven David Dykstra (1 out of 2 patents)

5. Henry Havel (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Iterion Therapeutics, Inc.. Retrieved from https://idiyas.com/company/iterion-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]